A new study has identified a potential mechanism to control the Epstein-Barr virus (EBV), a common herpesvirus carried by an estimated 95% of the global adult population. While often dormant, EBV can cause infectious mononucleosis and is linked to several cancers and multiple sclerosis. Researchers discovered that a specific viral protein, essential for the virus’s ability to switch between latent and active states, can be targeted. By inhibiting this protein, scientists were able to suppress viral reactivation in laboratory models, potentially preventing the diseases associated with EBV. This finding represents a significant step toward developing therapies that could control the virus in infected individuals. For the full details on this research, read the complete article at: https://www.sciencedaily.com/releases/2026/04/260414075650.htm